Avalo Therapeutics (AVTX) Cash & Current Investments (2014 - 2026)
Avalo Therapeutics (AVTX) reported Cash & Current Investments of $400.28 million for Q2 2026, up 253.4% from $113.26 million a year earlier and up 388.2% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Cash & Current Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, Avalo Therapeutics posted Cash & Current Investments of $98.34 million, down 26.9% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of 39.0% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $134.55 million in FY2024, $7.42 million in FY2023 (-43.7%), $13.17 million in FY2022 (-75.9%) and $54.59 million in FY2021 (+188.5%).
- The Q2 2026 figure ranks as the highest quarterly Cash & Current Investments in data going back to Q3 2014.
- Year over year, Cash & Current Investments gained in five of the last seven quarters, with growth averaging 138.2%.
- The high point for year-over-year Cash & Current Investments in five years was Q3 2024 (growth of 704.1%); the low point was Q3 2022 (a decline of 76.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $81.99 million (Q1 2026), $98.34 million (Q4 2025) and $111.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Avalo Therapeutics | 304.12 Mn | -388.10 Mn | - | 400.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 400.28 Mn |
| Mar 31, 2026 | 81.99 Mn |
| Dec 31, 2025 | 98.34 Mn |
| Sep 30, 2025 | 111.62 Mn |
| Jun 30, 2025 | 113.26 Mn |
| Mar 31, 2025 | 125.05 Mn |
| Dec 31, 2024 | 134.55 Mn |
| Sep 30, 2024 | 81.86 Mn |
| Jun 30, 2024 | 93.43 Mn |
| Mar 31, 2024 | 110.18 Mn |
| Dec 31, 2023 | 7.42 Mn |
| Sep 30, 2023 | 10.18 Mn |
| Jun 30, 2023 | 6.31 Mn |
| Mar 31, 2023 | 16.69 Mn |
| Dec 31, 2022 | 13.17 Mn |
| Sep 30, 2022 | 16.94 Mn |
| Jun 30, 2022 | 11.25 Mn |
| Mar 31, 2022 | 38.47 Mn |
| Dec 31, 2021 | 54.59 Mn |
| Sep 30, 2021 | 71.51 Mn |
API Access
Avalo Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();